$ESNT

Bhasin Vijay sold $992K of ESNT

Bhasin Vijay (SVP and Chief Risk Officer) sold 14,175 shares of Essent Group Ltd. (ESNT) at $70.00 ($0.99M total) on 2026-08-18 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bhasin Vijay
Published Aug 18, 2026, 8:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 8:53 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ESNT
Neutral
high confidence
Mentioned
$ESNT
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ESNTNeutralLow
01

Why it matters

The only actionable item is the disclosed sale size, price, and post-transaction holdings; it does not include guidance, legal/regulatory developments, or operational changes.

02

Market read

Traders may note insider selling, but the 10b5-1 pre-arranged nature makes it a low-conviction signal.

03

What to watch

The filing does not disclose reasons for sale, and the transaction size may be consistent with scheduled liquidity needs rather than a view on valuation or risk.

Relevance 4/10Novelty 3/10Timing: filed same day as the sale date (2026-08-18)

Background

The article is an SEC Form 4 insider transaction disclosure for Essent Group Ltd.

Company-level read

Ticker impact

$ESNTNeutralHigh confidence
Context

Essent Group Ltd. insider Bhasin Vijay (SVP and Chief Risk Officer) sold 14,175 shares at $70 on 2026-08-18 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; treat as low-signal unless paired with other disclosures.

Evidence & confidence

Form 4 details a pre-arranged 10b5-1 sale, which typically reduces interpretive weight versus discretionary selling.

Market effects

No direct sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with internal caution; monitor for clustering of sales or other negative filings.

Key entities

  • Essent Group Ltd.

    Subject of the Form 4 insider sale disclosure.

  • Bhasin Vijay

    SVP and Chief Risk Officer who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ESNTMedAI 8/10

Essent Group profit rises 7% as new P&C segment grows

Essent Group reported 2Q net income of $189.7 million, or $2.08 per diluted share, up from $177 million, or $1.93, a year earlier. Profit rose as its P&C reinsurance expansion increased premiums. P&C net premiums were $249 million for 1H 2026, and net premiums earned rose to $73 million. Essent expects $320 million written P&C premium in 2026 and declared a 35-cent quarterly dividend.

$ESNTMedAI 8/10

Essent Group (NYSE:ESNT) Delivers Strong Q2 CY2026 Numbers

Essent Group (NYSE:ESNT) reported Q2 2026 revenue of $362.7 million, up 13.6% year on year, beating Wall Street estimates by 9.7%. GAAP profit was $2.08 per share, 19.3% above consensus. The article also cites book value per share growth of about 11.7% over five years and notes the stock rose 2.4% to $67.08 after results.

$ESNTMed

Unilever, Barclays & Shell: Markets live

Unilever (ULVR) shares rose after it upgraded full-year outlook on improving sales. It reported €25.6bn revenue and €4.66bn pre-tax profit for six months to 30 June, with underlying sales up 4.8%. Other FTSE movers included Barclays (BARC) guidance and buyback, Forterra (FORT) results, and Canal+ (CAN) profit jump tied to MultiChoice consolidation.